GI 360 Microbiome Profile
Mosaic Diagnostics
Sample type: Stool
Requires fasting: No
At home test
Details
The GI 360 Miocriobiome profile provides a focused gut microbiome DNA analysis tool that identifies 45 targeted analytes across six phyla using a CE-marked multiplex PCR system providing dysbiosis, abundance and diversity assessments of the gut microbiome based on these 45 peer reviewed analytes shown to contribute to dysbiosis and other chronic disease states.
- Prevotella spp.
- Veillonella spp.
- Faecalibacterium prausnitzii
- Akkermansia muciniphila
- Lactobacillus spp.
- Bifidobacterium spp.
- Escherichia spp.
- Streptococcus spp.
- Firmicutes
- Bacteroides fragilis
- Acinetobacter junii
- Actinobacteria
- Actinomycetales
- Alistipes onderdonkii
- Alistipes spp.
- Bacilli class
- Bacteroides pectinophilus
- Bacteroides spp.
- Bacteroides stercoris
- Bacteroides zoogleoformans
- Catenibacterium mitsuokai
- Clostridium methylpentosum
- Coprobacillus cateniformis
- Dialister invisus
- Dorea spp.
- Enterobacteriaceae
- Eubacterium biforme
- Eubacterium hallii
- Eubacterium rectale
- Eubacterium siraeum
- Lachnospiraceae
- Mycoplasma hominis
- Parabacteroides johnsonii
- Phascolarctobacterium spp.
- Proteobacteria
- Ruminococcus gnavus
- Ruminococcus bromii
- Streptococcus agalactiae
- Ruminococcus albus
- Pediococcus acidilactici
- Lactobacillus ruminis
- Megasphaera micronuciformis
- Clostridia Class
- Clostridium L2-50
- Dysbiosis Index
- Streptococcus thermophilus
- Streptococcus sanguinis
Estimated days for results: Results should arrive 10 business days after the lab receives samples.
The GI360™ Microbiome Profile provides a focused gut microbiome DNA analysis. It includes:
- PCR Analysis for the Dysbiosis, Abundance, and Diversity of Key Bacterial Populations of the GI Microbiome
Microbiome Abundance and Diversity:
The GI360 Microbiome Profile is a gut microbiota DNA analysis tool that identifies and characterizes the abundance and diversity of more than 45 targeted analytes that peer-reviewed research has shown to contribute to dysbiosis and other chronic disease states.
The Dysbiosis and Diversity Index:
These indices are calculated from the results of the Microbiome Profile, with scores ranging from 1 to 5, and do not include consideration of dysbiotic and pathogenic bacteria, yeast, parasites, and viruses that may be reported in subsequent sections of the GI360 test.
A dysbiosis score above 2 indicates dysbiosis - a microbiota profile that differs from the defined normobiotic reference population. The higher the score above 2, the more the sample deviates from the normobiotic profile.
A diversity score of 3 indicates an expected amount of diversity, while scores of 4 and 5 indicate an increased distribution of bacteria based on the number of different species and their abundance in the sample, calculated based on Shannon’s diversity index. Scores of 1 or 2 indicate less diversity than the defined normobiotic reference population.
10 business days
Before You Start
- Follow the test collection instructions here.
- DO NOT collect your sample while menstruating or actively bleeding from hemorrhoids.
- Ship your samples Monday - Wednesday only.
2 Weeks Before Collection
- Avoid the following medications. DO NOT discontinue any prescription medications without first consulting your healthcare provider.
- Antibiotics
- Antiparasitics
- Antifungals
- Probiotic supplements
- Proton pump inhibitors (PPIs)
- Bismuth
48 Hours Before Collection
- Avoid the following foods and medications. DO NOT discontinue any prescription medications without first consulting your healthcare provider.
- Digestive enzymes
- Antacids
- Aspirin or other NSAIDs
- Laxatives
- Activated charcoal
- Betaine HCI
- Bentonite clay
24 Hours Before Collection
- DO NOT use suppositories or mineral oil before sample collection.
- If you have trouble producing stool, you may use one of the following:
- Oral phosphate soda laxatives (e.g., Fleet)
- Magnesium citrate
- Psyllium fiber
- Enemas using distilled water only
State restrictions:
Patient can't order this test if they are located in Hawaii, Puerto Rico, New Jersey, New York, or Rhode Island
